Clinical trial
Argatroban Stroke Treatment - A Pilot Safety Study
NCT00268762 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00268762 |
|---|---|
| Title | Argatroban Stroke Treatment - A Pilot Safety Study |
| Official title | A Pilot Study To Determine The Safety Of Argatroban Injection In Combination With Tissue Plasmingen Activator (TPA) In Patients With Acute Ischemic Stroke |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug |
| Interventions | argatroban |
| Enrollment | 65 |
| Start date | Feb 1, 2003 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Dec 22, 2005 |
| Last update posted | Nov 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: